Paul Colussi
Paul Colussi is the head of protein expression at Tetragenetics Inc
Articles
An Alternative Platform for Rapid Production of Effective Subunit Vaccines
Judith A. Appleton;Donna Cassidy-Hanley;Ashot Papoyan;Lucille Gagliardo;Xujie Zhang;Theodore G. Clark;Jyothi Jayaram;Yelena Bisharyan;Paul Colussi
October 2nd 2010Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Latest Updated Articles
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
